DelSiTech Ltd Receives Funding for the Stabilization of Viral Vaccines - Awarded a grant for vaccine development by the Bill & Melinda Gates Foundation
DelSiTech Ltd, a Finnish drug delivery and drug development company, today announced significant grant funding to support the development of thermostabilized viral vaccines from the Bill & Melinda Gates Foundation. DelSiTechTMSilica Matrix is an advanced, sustained and controlled release delivery technology for administration of injectable, implant and topical eye drop dosage forms. One